Chao L.-WLING-HUNG WEI2020-02-122020-02-1220091028-4559https://scholars.lib.ntu.edu.tw/handle/123456789/458238[SDGs]SDG3antinuclear antibody; CA 125 antigen; CA 15-3 antigen; carboplatin; creatine kinase; doxorubicin; paclitaxel; steroid; abdominal distension; abdominal hysterectomy; adjuvant chemotherapy; adjuvant therapy; adult; ascites fluid cytology; cancer combination chemotherapy; cancer grading; cancer staging; cancer surgery; case report; cheek; climbing; computer assisted tomography; cooking; creatine kinase blood level; cytoreductive surgery; dermatomyositis; edema; electromyography; face erythema; female; forehead; histopathology; human; laparotomy; letter; lymph node dissection; mammography; menopause; metastasis; motor dysfunction; multipara; multiple cycle treatment; muscle weakness; myopathy; nuclear magnetic resonance imaging; omental metastasis; ovary adenocarcinoma; papule; pelvis lymph node; recurrent cancer; salpingooophorectomy; salvage therapy; skin biopsy; telangiectasia; transvaginal echography; Dermatomyositis; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paraneoplastic Syndromesletter10.1016/S1028-4559(09)60283-7195741842-s2.0-67651091640